Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ueoka, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shimono, M; Hiraki, A; Ueoka, H; Tanimoto, Y; Aoe, M; Sakae, K; Kaneda, K; Sakugawa, M; Kiura, K; Harada, M
      Successful treatment with concurrent chemoradiotherapy followed by surgeryfor a patient with thymic adenocarcinoma

      ANTICANCER RESEARCH
    2. Hiraki, A; Ono, T; Tanaka, M; Kiura, K; Ueoka, H; Kawai, H; Harada, M; Nakayama, E; Noguchi, Y
      Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis

      ANTICANCER RESEARCH
    3. Fujimoto, N; Hiraki, A; Ueoka, H; Harada, M
      Metastasis to the penis in a patient with squamous cell carcinoma of the lung with a review of reported cases

      LUNG CANCER
    4. Shibayama, T; Ueoka, H; Nishii, K; Kiura, K; Tabata, M; Miyatake, K; Kitajima, T; Harada, M
      Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)

      LUNG CANCER
    5. Ueoka, H; Tanimoto, M; Kiura, K; Tabata, M; Takigawa, N; Segawa, Y; Takata, I; Eguchi, K; Okimoto, N; Harita, S; Kamei, H; Shibayama, T; Watanabe, Y; Hiraki, S; Harada, M
      Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

      BRITISH JOURNAL OF CANCER
    6. Maeda, T; Ueoka, H; Tabata, M; Kiura, K; Shibayama, T; Gemba, K; Takigawa, N; Hiraki, A; Katayama, H; Harada, M
      Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    7. Takigawa, N; Segawa, Y; Ueoka, H; Kiura, K; Tabata, M; Shibayama, T; Takata, I; Miyamoto, H; Eguchi, K; Harada, M
      Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    8. Bessho, A; Tabata, M; Kiura, K; Takata, I; Nagata, T; Fujimoto, N; Kunisada, K; Ueoka, H; Harada, M
      Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction

      ANTICANCER RESEARCH
    9. Fujimoto, N; Hiraki, A; Ueoka, H; Kiura, K; Bessho, A; Takata, I; Hiramatsu, Y; Ikeda, K; Harada, M
      Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer

      LUNG CANCER
    10. Gemba, K; Ueoka, H; Kiura, K; Tabata, M; Harada, M
      Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome

      LUNG CANCER
    11. Mimoto, J; Kiura, K; Matsuo, K; Yoshino, T; Takata, I; Ueoka, H; Kataoka, M; Harada, M
      (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice

      CARCINOGENESIS
    12. Ueoka-Nakanishi, H; Maeshima, M
      Quantification of Ca2+/H+ antiporter VCAX1p in vacuolar membranes and its absence in roots of mung bean

      PLANT AND CELL PHYSIOLOGY
    13. Ueoka-Nakanishi, H; Tsuchiya, T; Sasaki, M; Nakanishi, Y; Cunningham, KW; Maeshima, M
      Functional expression of mung bean Ca2+/H+ antiporter in yeast and its intracellular localization in the hypocotyl and tobacco cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    14. Ando, Y; Saka, H; Ando, M; Sawa, T; Muro, K; Ueoka, H; Yokoyama, A; Saitoh, S; Shimokata, K; Hasegawa, Y
      Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity:A pharmacogenetic analysis

      CANCER RESEARCH
    15. Segawa, Y; Ueoka, H; Kiura, K; Kamei, H; Tabata, M; Sakae, K; Hiraki, Y; Kawahara, S; Eguchi, K; Hiraki, S; Harada, M
      A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

      BRITISH JOURNAL OF CANCER
    16. Hiraki, A; Kaneshige, T; Kiura, K; Ueoka, H; Yamane, H; Tanaka, M; Harada, M
      Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer

      CLINICAL CANCER RESEARCH
    17. Hiraki, A; Ueoka, H; Yoshino, T; Chikamori, KI; Onishi, K; Kiura, K; Bessho, A; Mimoto, J; Date, H; Ando, A; Shimizu, N; Harada, M
      Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: Diagnosis and treatment

      ONCOLOGY REPORTS
    18. Emori, Y; Kiura, K; Yoshino, T; Notohara, K; Tsuchida, T; Yokoyama, M; Nogami, N; Kataoka, M; Ueoka, H; Harada, M
      Very young patient with peculiar squamous cell carcinoma of the lung

      INTERNAL MEDICINE
    19. Yamane, H; Bessho, A; Kiura, K; Tabata, M; Katayama, Y; Motoda, K; Tsuchida, T; Nogami, N; Hiraki, A; Ueoka, H; Harada, M
      Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer

      INTERNAL MEDICINE
    20. Matsushita, A; Tabata, M; Ueoka, H; Kiura, K; Shibayama, T; Aoe, K; Kohara, H; Harada, M
      Establishment of a drug sensitivity panel using human lung cancer cell lines

      ACTA MEDICA OKAYAMA
    21. Ikubo, S; Takigawa, N; Ueoka, H; Kiura, K; Tabata, M; Shibayama, T; Chikamori, M; Aoe, K; Matsushita, A; Harada, M
      In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines

      ANTICANCER RESEARCH
    22. Bessho, A; Ueoka, H; Kiura, K; Tabata, M; Sunami, K; Katayama, Y; Yamane, H; Hiraki, A; Harada, M
      High-dose ifosfamide, carboplatin and etoposide with autologous peripheralblood progenitor cell transplantation for small-cell lung cancer

      ANTICANCER RESEARCH
    23. Aoe, K; Kiura, K; Ueoka, H; Tabata, M; Matsumura, T; Chikamori, M; Matsushita, A; Kohara, H; Harada, M
      Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines

      ANTICANCER RESEARCH
    24. Auperin, A; Arriagada, R; Pignon, JP; Le Pechoux, C; Gregor, A; Stephens, RJ; Kristjansen, PEG; Johnson, BE; Ueoka, H; Wagner, H; Aisner, J
      Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission

      NEW ENGLAND JOURNAL OF MEDICINE
    25. Ueoka-Nakanishi, H; Nakanishi, Y; Tanaka, Y; Maeshima, M
      Properties and molecular cloning of Ca2+/H+ antiporter in the vacuolar membrane of mung bean

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    26. Ueoka, H; Tabata, M; Kiura, K; Shibayama, T; Gemba, K; Segawa, Y; Chikamori, K; Yonei, T; Hiraki, S; Harada, M
      Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

      BRITISH JOURNAL OF CANCER
    27. TAMURA M; UEOKA H; KIURA K; TABATA M; SHIBAYAMA T; MIYATAKE K; GEMBA K; HIRAKI S; HARADA M
      PROGNOSTIC FACTORS OF SMALL-CELL LUNG-CANCER IN OKAYAMA LUNG-CANCER STUDY-GROUP TRIALS

      Acta medica Okayama
    28. KIURA K; WATARAI S; UEOKA H; TABATA M; GEMBA KI; AOE K; YAMANE H; YASUDA T; HARADA M
      AN ALTERATION OF GANGLIOSIDE COMPOSITION IN CISPLATIN-RESISTANT LUNG-CANCER CELL-LINE

      Anticancer research
    29. MORITAKA T; KIURA K; UEOKA H; TABATA M; SEGAWA Y; SHIBAYAMA T; TAKIGAWA N; OHNOSHI T; HARADA M
      CISPLATIN-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE SHOWS COLLATERAL SENSITIVITY TO VINCA ALKALOIDS

      Anticancer research
    30. HIRAKI A; UEOKA H; TABATA M; KIURA K; BESSHO A; YAMANE H; NOGAMI N; HARADA M
      SPONTANEOUS BILOMA AS A COMPLICATION OF SMALL-CELL LUNG-CANCER

      Lung cancer
    31. UEOKA H; KIURA K; TABATA M; KAMEI H; GEMBA K; SAKAE K; HIRAKI Y; HIRAKI S; SEGAWA Y; HARADA M
      A RANDOMIZED TRIAL OF HYBRID ADMINISTRATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE (CAV) CISPLATIN AND ETOPOSIDE (PVP) VERSUS SEQUENTIAL ADMINISTRATION OF CAV-PVP FOR THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CARCINOMA - RESULTS OF LONG-TERM FOLLOW-UP

      Cancer
    32. HIRAKI A; TABATA M; UEOKA H; KIURA K; SHIBAYAMA T; YAMANE H; HARADA M
      DIRECT INTRACEREBRAL INVASION FROM SKULL METASTASIS OF LARGE-CELL LUNG-CANCER

      Internal medicine
    33. KOHARA H; UEOKA H; TABATA M; SHINAGAWA K; HAYASHI K; HARADA M
      HIGH-DOSE ETOPOSIDE TREATMENT FOR CNS INVOLVEMENT IN A PATIENT WITH PRIMARY NON-HODGKINS-LYMPHOMA OF THE BREAST

      Internal medicine
    34. MATSUO K; KIURA K; UEOKA H; TABATA M; SHIBAYAMA T; MATSUMURA T; TAKIGAWA N; HIRAKI S; HARADA M
      GROWTH-INHIBITORY EFFECTS OF ANTIFOLATES AGAINST AN ADRIAMYCIN-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE

      Acta medica Okayama
    35. SEGAWA Y; TAKIGAWA N; KATAOKA M; TAKATA I; FUJIMOTO N; UEOKA H
      RISK-FACTORS FOR DEVELOPMENT OF RADIATION PNEUMONITIS FOLLOWING RADIATION-THERAPY WITH OR WITHOUT CHEMOTHERAPY FOR LUNG-CANCER

      International journal of radiation oncology, biology, physics
    36. YAMANE H; KIURA K; TABATA M; BESSHO A; TSUCHIDA T; MOTODA K; HIRAKI A; UEOKA H; HARADA M
      SMALL-CELL LUNG-CANCER CAN EXPRESS CD34 ANTIGEN

      Anticancer research
    37. UEOKA H; HASE A
      TONOPLAST H-ARTICHOKE (HELIANTHUS-TUBEROSUS)( PUMPS ARE ACTIVATED DURING CALLUS FORMATION OF TUBER TISSUES OF JERUSALEM)

      Physiologia Plantarum
    38. TESHIMA T; SUNAMI K; BESSHO A; SHINAGAWA K; OMOTO E; UEOKA H; HARADA M; OHNO Y; MIYOSHI T; MIYAMOTO T; HIGUCHI M
      CIRCULATING IMMATURE CELL COUNTS ON THE HARVEST DAY PREDICT THE YIELDS OF CD34(-COLONY-STIMULATING FACTOR PLUS CHEMOTHERAPY-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELL() CELLS COLLECTED AFTER GRANULOCYTE)

      Blood
    39. HOSHINO K; TANIGUCHI M; UEOKA H; OHKUWA M; CHIDA C; MOROHASHI S; SASAKURA T
      REPEATED UTILIZATION OF BETA-GLUCOSIDASE IMMOBILIZED ON A REVERSIBLY SOLUBLE-INSOLUBLE POLYMER FOR HYDROLYSIS OF PHLORHIZIN AS A MODEL REACTION PRODUCING A WATER-INSOLUBLE PRODUCT

      Journal of fermentation and bioengineering
    40. KATAOKA M; MORISHITA R; HIRAMATSU J; UEOKA H; NAKATA Y; OHNOSHI T; KIMURA I; HARADA M
      OK-432 INDUCES PRODUCTION OF NEUTROPHIL CHEMOTACTIC FACTORS IN MALIGNANT PLEURAL EFFUSION

      Internal medicine
    41. HASHIMOTO T; OHTAKI M; UEOKA H; MUNAKA M; KURAMOTO A; KAMADA N
      ESTIMATION OF CHRONIC PHASE DURATION IN PH-POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA TREATED WITH BUSULFAN - STATISTICAL-ANALYSIS ON JAPANESE PATIENTS

      International journal of hematology
    42. OHNOSHI T; HIRAKI S; UEDA N; FUJII M; MACHIDA K; UEOKA H; YONEI T; KIURA K; KAMEI H; SEGAWA Y; TABATA M; SHIBAYAMA T; MIYATAKE K; MAEDA T; KIMURA I
      LONG-TERM RESULTS OF COMBINATION CHEMOTHERAPY WITH OR WITHOUT IRRADIATION IN SMALL-CELL LUNG-CANCER - A 5-YEAR TO 11-YEAR FOLLOW-UP

      Internal medicine
    43. YONEI T; OHNOSHI T; HIRAKI S; UEOKA H; KIURA K; MORITAKA T; SHIBAYAMA T; TABATA M; SEGAWA Y; TAKIGAWA N; KIMURA I
      ANTITUMOR-ACTIVITY OF PLATINUM ANALOGS AGAINST HUMAN LUNG-CANCER CELL-LINES AND TUMOR SPECIMENS

      Acta medica Okayama
    44. TABATA M; OHNOSHI T; UEOKA H; KIURA K; KIMURA I
      MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN SMALL-CELL LUNG-CANCER - MDR1 GENE-EXPRESSION AS AN INDEPENDENT PROGNOSTIC FACTOR

      Acta medica Okayama
    45. SEGAWA Y; OHNOSHI T; UEOKA H; KIMURA I
      NEURAL CELL-ADHESION MOLECULE EXPRESSION AND CLINICAL-FEATURES IN SMALL-CELL LUNG-CANCER - A SEMIQUANTITATIVE IMMUNOHISTOCHEMICAL APPROACH USING AN IMMUNOGOLD-SILVER STAINING METHOD

      Acta medica Okayama
    46. SEGAWA Y; OHNOSHI T; HIRAKI S; UEOKA H; KIURA K; KAMEI H; TABATA M; SHIBAYAMA T; MIYATAKE K; GENBA K; MATSUMURA T; KIMURA I
      IMMUNOHISTOCHEMICAL DETECTION OF P-GLYCOPROTEIN AND CARCINOEMBRYONIC ANTIGEN IN SMALL-CELL LUNG-CANCER - WITH REFERENCE TO PREDICTABILITY OF RESPONSE TO CHEMOTHERAPY

      Acta medica Okayama
    47. OHNOSHI T; HIRAKI S; FUJII M; UEOKA H; YONEI T; TAMURA M; MORITAKA T; MIMA Y; HORIGUCHI T; KIURA K; KAMEI H; KODANI T; HIRAKI Y; KIMURA I
      MORTALITY AND MORBIDITY IN 2-YEAR DISEASE-FREE SURVIVORS OF SMALL-CELL LUNG-CANCER AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY WITH OR WITHOUT IRRADIATION

      Acta medica Okayama
    48. OHONOSHI T; UEOKA H; KAWAHARA S; KIURA K; KAMEI H; HIRAKI Y; SEGAWA Y; HIRAKI S; KIMURA I
      COMPARATIVE-STUDY OF PROPHYLACTIC CRANIAL IRRADIATION IN PATIENTS WITH SMALL-CELL LUNG-CANCER ACHIEVING A COMPLETE RESPONSE - A LONG-TERM FOLLOW-UP RESULT

      Lung cancer
    49. OHNOSHI T; HIRAKI S; UEOKA H; KIURA K; KAMEI H; HORIGUCHI T; KODANI T; MAEDA T; TABATA M; SHIBAYAMA T; SEGAWA Y; MIYATAKE K; TAKIGAWA N; KIMURA I
      PILOT-STUDY OF HAMIDE-DOXORUBICIN-VINCRISTINE-CISPLATIN-ETOPOSIDE HYBRID CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 20:05:35